Loading...

Quintessential serial acquirer

Published
06 Feb 26
Views
41
n/a
n/a
alex30free's Fair Value
n/a
Loading
1Y
-26.8%
7D
-5.0%

Author's Valuation

SEK 256.8613.6% undervalued intrinsic discount

alex30free's Fair Value

1. The Decentralized Compounder

Indutrade’s narrative is built on the Swedish Serial Acquirer model, a story of stability through extreme diversification

  • De-centralization: Unlike traditional conglomerates that centralize power, Indutrade’s narrative is small is beautiful. They own over 200 companies but keep them independent. This preserves the entrepreneurial spirit and prevents the "diseconomies of scale" that you normally see in large mergers
  • Discipline: Indutrade does not buy for synergies (a word you here 99 out of 100 times). Instead, they buy well-managed, niche B2B companies with proprietary products. The narrative is: "We provide a permanent home for great small businesses, not a restructuring platform"
  • The Pivot to Science: In 2025/2026, the narrative has shifted slightly toward Life Sciences and Green Tech. By acquiring companies in medical tech and energy transition, they are moving the portfolio toward higher-multiple, structural growth areas

2. Numbers: Validating the Acquisition Machine

3. Valuation Bridge: Price vs. Value

Indutrade’s value is highly sensitive to the Reinvestment Rate and Marginal ROIC

  • The Premium Multiple: Indutrade often trades at a high P/E, often >30x (3,5,7-year averages at ~36). This is a Quality Premium paid for their low risk and high consistency
  • The Growth Cap: The main constraint on the narrative is the size of the target market. As Indutrade gets larger, they must acquire more companies or larger companies to maintain the 10% total growth target. This increases the risk of overpaying, which would be the primary threat to the story

4. Possible breaks & Red flags

A break for Indutrade would occur if:

  1. Centralization Creep: If the head office starts interfering with subsidiaries, the "Entrepreneurial" story fails
  2. Margin Compression: If they move away from high-tech niche toward commodity trading to find bigger targets, the >14% EBITA margin will collapse
  3. Interest Rate Spikes: As a serial acquirer, their raw material is capital. If borrowing costs stay high for years, the spread between their ROCE and WACC narrows, destroying the compounding effect

Summary

Indutrade is a High-Moat, Low-Growth-Organic business that excels at Capital Allocation. You aren't buying a manufacturer, you are buying a fund manager that specializes in Swedish industrial SMEs

Extra 1: The swedish serial acquirer landscape

Indutrade is often the benchmark for stability and diversification. However, as of early 2026, a clear hierarchy has emerged based on capital efficiency (ROCE) and profitability (EBITA margin)

While Indutrade is a high-quality all-rounder, companies like Lifco and Addtech have recently outperformed it on the two metrics: the ability to generate high returns on invested capital and the power to maintain superior margins

Financial KPI Comparison (2025/2026e)

1. Lifco: The Gold Standard for Profitability

Lifco is structurally superior in its ability to extract high margins. With an EBITA margin exceeding 22%, it far outpaces Indutrade’s ~14%

  • Lifco targets businesses with pricing power (like dental consumables and demolition robots), resulting in the most resilient cashflow profile in the group

2. Addtech: The High-Return Compounder

While Indutrade is more diversified, Addtech is more specialized in megatrend areas like the green energy transition and automation

  • ROCE of ~22% is world-class. It is currently favoured by the market because its subsidiaries are perfectly positioned for the European electrification wave

3. AddLife: The Turnaround and Growth Play

AddLife (spun off from Addtech) focuses entirely on MedTech and LabTech. It has lower margins than the others because it is still working through a post-pandemic reset

  • Here we are looking at a recovery. While its current ROCE is the lowest in this group, its organic growth potential in life sciences is among the highest

4. Lagercrantz: The High Margin Product Specialist

Lagercrantz has successfully shifted from being a trader to a product owner

  • By owning its own niche products, it maintains a superior margin profile ~17% compared to Indutrade. It currently scores very high on quality of earnings

5. OEM International: The Capital Efficiency Master

OEM is often the hidden gem of this group. It has a significantly higher ROCE (25%+) than Indutrade because it operates an extremely asset-light trading model

  • OEM generates massive returns on very little invested capital. It is less of an acquisition machine than Lifco but more efficient with every krona it keeps

Summary

If you are looking for the best Capital Allocation Machine, the data suggests that Lifco (for margins) and Addtech (for returns) currently provide a more robust narrative than Indutrade. Indutrade remains the safest due to its sheer size and 200+ companies, but its Alpha (excess return) is currently trending slightly lower than its peers

EXTRA 2: Growth vs. Value

Adding Total Growth provides the final piece of the puzzle. Growth is only valuable if it is accompanied by a ROCE that exceeds the cost of capital

As of early 2026, Addtech and Lagercrantz lead the group in total growth, largely driven by their aggressive acquisition pace in high-demand green-tech and electrification niches

Full KPI matrix (2025/2026e)

  • The High-Growth Leaders: Addtech ~15% and Lagercrantz ~14% are the most aggressive acquirers right now. Because their ROCE is high (>21%), this growth is creating significant shareholder value. This justifies their premium EV/FCF multiples compared to Indutrade
  • The Quality Discount: OEM International has the lowest total growth ~7% but the highest efficiency, 25% ROCE. It is the most conservative machine in the group, which is why it trades at the lowest valuation, i.e. 22x EV/FCF
  • The Growth/Value Sweet Spot: Lifco manages to combine double-digit growth ~13% with industry-leading margins, 22.4%. This double threat is why it remains the favourite of many institutional investors despite the 28x EV/FCF multiple
  • The Lagging Narrative: AddLife is currently in a consolidation phase. Its growth is the lowest in the group and its ROCE hasn't yet recovered to pre 2024 levels, making its 31x EV/FCF multiple look particularly expensive relative to its peers

I have tried to create a scoring model, to get some kind of toplist and have normalized the data on a scale of 0 to 10. The score is weighted to favour for Efficiency (40% ROCE), while giving equal weight to Cash Generation (30% FCF Margin) and Attractiveness of Price (30% EV/FCF)

  • The Winner: OEM International (8.61) OEM takes the top spot because it sweeps the metrics. It has the highest ROCE of 25% and the lowest valuation at 22x EV/FCF, creating a massive margin of safety. While its growth is slower than Lifco's, its fundamental efficiency is unbeatable in this peer group

This ranking helps you visualize where you are getting the most quality for every swedish krona invested, as we say in Sweden ;)

Have other thoughts on Indutrade?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

The user alex30free holds no position in OM:INDT. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

SEK 314.62
FV
29.5% undervalued intrinsic discount
10.16%
Revenue growth p.a.
18
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SEK 271.67
FV
18.4% undervalued intrinsic discount
8.76%
Revenue growth p.a.
38
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative